Novilla - About the company
Novilla is a funded company based in Arlington (United States), founded in 2019 by Shashi Kori. It operates as a Developer of pain therapeutics for opioid treatment. The company has 304 active competitors, including 81 funded and 89 that have exited. Its top competitors include companies like argenx, Vor Biopharma and Horizon Therapeutics.
Company Details
Developer of pain therapeutics for opioid treatment. It offers a platform that utilizes patented drug delivery mechanisms that bypass the most common route of administration- the bloodstream to get local administration of Opioid Alternatives and successful pain management therapies.
- Website
- www.novilla.com/
- Email ID
- *****@novilla.com
Key Metrics
Founded Year
2019
Location
Arlington, United States
Stage
Funding Raised
Investors
Ranked
140th among 304 active competitors
Employee Count
13 as on Aug 31, 2026
Similar Companies
Sign up to download Novilla's company profile
Novilla's funding and investors
Novilla is a funded company. Novilla has 1 institutional investor.
View details of Novilla's funding rounds and investors
Novilla's founders and board of directors
Founder? Claim ProfileThe founders of Novilla is Shashi Kori. Shashi Kori is the CEO of Novilla.
Here are the details of Novilla's key team members:
- Shashi Kori: Co-Founder & CEO of Novilla. Contact Info: 1 email address
View details of Novilla's Founder profiles and Board Members
Novilla's employee count trend
Novilla has 13 employees as of Aug 26. Here is Novilla's employee count trend over the years:
Uncover Novilla's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Novilla's Competitors and alternates
Top competitors of Novilla include argenx, Vor Biopharma and Horizon Therapeutics. Here is the list of Top 10 competitors of Novilla, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of antibody-based drugs to treat autoimmune diseases and cancer | $61.9M | 75/100 | ||
2nd |  Vor Biopharma 2019, Cambridge (United States), Public | Developer of therapeutics to treat acute myeloid leukemia | $152M | 68/100 | |
3rd | Horizon Therapeutics 2008, Dublin (Ireland), Acquired | Developer of drugs for treating rare and autoimmune diseases | $61.8M | 64/100 | |
4th | Heron Therapeutics 1983, Redwood City (United States), Public | Pharmaceutical company focused on acute care and oncology with innovative therapies | - | 63/100 | |
5th | Radius Health 2003, Boston (United States), Acquired | Biopharmaceutical company focused on bone health and related therapeutic areas | $213M | 63/100 | |
6th | Xenon Pharmaceuticals 2000, Burnaby (Canada), Public | Developer of small molecule drugs against rare channelopathies | $85.7M | 62/100 | |
7th | Collegium Pharma 2002, Canton (United States), Public | Developer of therapeutics for chronic pain management | $103M | 62/100 | |
8th | Quince Therapeutics 2012, San Francisco (United States), Public | Developer of therapeutics for orthopedic diseases | $108M | 60/100 | |
9th |  Foresee Pharmaceuticals 2011, Taipei (Taiwan), Public | Developer of injectables and NCEs for cancer and chronic diseases | $32.5M | 59/100 | |
10th |  Angitia 2018, Woodland Hills (United States), Series D | Developer of drugs for muscle, bone, and joint diseases | $406M | 58/100 | |
140th |  Novilla 2019, Arlington (United States), Funding Raised | Developer of pain therapeutics for opioid treatment | - | 25/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Novilla's competitors? Click here to see the top ones
Novilla's Investments and acquisitions
Novilla has made no investments or acquisitions yet.
Reports related to Novilla
Here is the latest report on Novilla's sector:
Are you a Founder ?
FAQs about Novilla
Explore our recently published companies
- Gran Hotel Claridge - Granada based, 2026 founded, Unfunded company
- Accept Crypto - 2026 founded, Unfunded company
- SensorToGo - Cincinnati based, 2026 founded, Unfunded company
